1.Recurrence following transanal total mesorectal excision for rectal cancer: a monocentric retrospective series of technically difficult cases
Jonathan FRIGAULT ; Geneviève MORIN ; Sébastien DROLET ; Philippe BOUCHARD ; Alexandre BOUCHARD ; Thanh-Quan Philips NGO ; François LETARTE
Annals of Coloproctology 2023;39(4):332-341
Purpose:
Transanal total mesorectal excision (TaTME) has been proposed to overcome surgical difficulties encountered during rectal resection, especially for patients having high body mass index or low rectal cancer. The aim of this study was to evaluate oncologic outcomes following TaTME.
Methods:
This retrospective study included all consecutive patients with rectal cancer who had a TaTME from 2013 to 2019. The main outcome was the incidence of locoregional recurrence by the end of the follow-up period.
Results:
Among a total of 81 patients, 96.3% were male, and their mean age was 63±9 years. The mean body mass index was 30.3±5.7 kg/m2, and the median distance from tumor to anal verge was 5.0 cm (interquartile range [IQR], 4.0–6.0 cm). Most patients had a low anterior resection performed (n=80, 98.8%) with a diverting ileostomy (n=64, 79.0%). Distal and circumferential resection margins were positive in 2.5% and 6.2% of patients, respectively. Total mesorectal excision was complete or near complete in 95.1% of patients. A successful resection was achieved in 72 patients (88.9%). After a median follow-up of 27.5 months (IQR, 16.7–48.1 months), 4 patients (4.9%) experienced locoregional recurrence. Anastomotic leaks were observed in 21 patients (25.9%). At the end of the follow-up, 69 patients (85.2%) were stoma-free.
Conclusion
TaTME was associated with acceptable oncological outcomes, including low locoregional recurrence rates in selected patients with low rectal cancer. Although associated with a high incidence of postoperative morbidities, the use of TaTME enabled a high rate of successful sphincter-saving procedures in selected patients who posed a technical challenge.
2.Alanyl-tRNA Synthetase 2-Related Dementia with Selective Bilateral Frontal Cystic Leukoencephalopathy.
Guilhem CARLE ; Alexandre MORIN ; Camille NOIRAY ; Perrine ROY-JOLY ; Laurent COHEN ; Richard LEVY ; Simon SAMAAN ; Yann NADJAR
Journal of Clinical Neurology 2018;14(3):420-422
No abstract available.
Alanine-tRNA Ligase*
;
Dementia*
;
Leukoencephalopathies*
3.Cardiac Arrest Management in the Workplace: Improving but Not Enough?
Alexis DESCATHA ; François MORIN ; Marc FADEL ; Thomas BIZOUARD ; Romain MERMILLOD-BLONDIN ; Julien TURK ; Alexandre ARMAINGAUD ; Hélène DUHEM ; Dominique SAVARY
Safety and Health at Work 2023;14(1):131-134
The aim was to describe out-of-hospital cardiac arrest (OHCA) occurring in the workplace of a large emergency network, and compare the evolution of their management in the last 15 years. A retrospective study based on data from the Northern Alps Emergency Network compared characteristics of OHCA between cases in and out the workplace, and between cases occurring from January 2004 to December 2010 and from January 2011 to December 2017. Among the 15,320 OHCA cases included, 320 occurred in the workplace (2.1%). They were more often in younger men, and happened more frequently in an area with access to public defibrillation, had more often a shockable rhythm, had a cardiopulmonary resuscitation started by a bystander more frequently, and had a better outcome. Cardiopulmonary resuscitation started by a bystander was the only chain of survival link that improved for cases occurring after December 2010. Workplace OHCA seems to be managed more effectively than others; however, only a slight survival improvement was observed, suggesting that progress is still needed.